Wird geladen...
Cost Effectiveness of DCISionRT for Guiding Treatment of Ductal Carcinoma in Situ
The DCISionRT test estimates the risk of an ipsilateral breast event (IBE) in patients with ductal carcinoma in situ (DCIS) as well as the benefit of adjuvant radiation therapy (RT). We determined the cost-effectiveness of DCISionRT using a Markov model simulating 10-year outcomes for 60-year-old wo...
Gespeichert in:
| Veröffentlicht in: | JNCI Cancer Spectr |
|---|---|
| Hauptverfasser: | , , , |
| Format: | Artigo |
| Sprache: | Inglês |
| Veröffentlicht: |
Oxford University Press
2020
|
| Schlagworte: | |
| Online Zugang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7083239/ https://ncbi.nlm.nih.gov/pubmed/32211582 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/jncics/pkaa004 |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|